Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1035120190190010018
Asian Oncology Nursing
2019 Volume.19 No. 1 p.18 ~ p.26
Perception and Satisfaction of Anticancer Drug Clinical Trials in Cancer Patients
Jeon Ju-Kyung

Kim Jeong-Hye
Abstract
Purpose: The purpose of this study was to investigate the perception and satisfaction of cancer patients participating in clinical trials of anticancer drugs and the factors affecting their satisfaction.

Methods: The participants were cancer patients who participated in more than two cycles of clinical trials at a tertiary hospital in Seoul, Korea. Questionnaires were used to assess the perception and satisfaction of clinical trials of anticancer drugs.

Results: A total of 106 patients participated. The average perception and satisfaction regarding clinical trials among patients on a 5 point scale was 3.99¡¾0.45 and 4.09¡¾0.55 respectively. There was a significant difference in the correlation among participants' perception and their satisfaction (r =.67, p<.001). Regression analysis revealed that satisfaction was explained by, perception of clinical trials (¥â =.67, p<.001), participation period 30~59 days (¥â =.21, p=.009), and participation period over 60 days (¥â=.20, p=.013). These variables explained 48.7% of the variance of clinical trial satisfaction.

Conclusion: The results of this study suggest that changes in perceptions of clinical trials are needed to improve satisfaction of anticancer drug clinical trials. This can be used as a basis for improving the quality of clinical trials and education programs for cancer patients participating in clinical trials.
KEYWORD
Neoplasms, Clinical trial, Perception, Personal satisfaction
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed